{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:26:54Z","timestamp":1795040814379,"version":"4.10.2"},"reference-count":42,"publisher":"Georg Thieme Verlag KG","issue":"07","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"United Kingdom Research and Innovation","doi-asserted-by":"crossref","award":["10038000,10039823"],"award-info":[{"award-number":["10038000,10039823"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Union\u2019s Horizon Europe research and innovation","award":["101057292"],"award-info":[{"award-number":["101057292"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Data on risks and benefits of long-term anticoagulants in patients with a life-limiting disease are limited. This cohort study aims to describe (dis)continuation of anticoagulants and incidences of bleeding and thromboembolic events in vitamin K antagonist (VKA) users with a life-limiting disease.<\/jats:p>\n                  <jats:p>Data from five Dutch anticoagulation clinics were linked to data from Statistics Netherlands and the Netherlands Cancer registry. Prevalent VKA users diagnosed with a pre-specified life-limiting disease between January 1, 2013 and December 31, 2019 were included and followed until December 31, 2019. Bleeding and thromboembolic events were identified by hospitalization data. Cumulative incidences of anticoagulant discontinuation, accounting for death as competing risk, and event rates for both anticoagulant exposed and unexposed person-years (PYs) were determined.<\/jats:p>\n                  <jats:p>Among 18,145 VKA users (median age 81 years [IQR: 74\u201386], 49% females, median survival time 2.03 years [95%CI: 1.97\u20132.10]), the most common life-limiting diseases were heart disease (60.0%), hip fracture (18.1%), and cancer (13.5%). One year after diagnosis, the cumulative incidence of anticoagulant discontinuation was 14.0% (95%CI: 13.5\u201314.6). Over 80% of patients continued anticoagulant therapy until the last month before death, with median 14 days between discontinuation and death. Event rates per 100 PYs (95%CI) were comparable during anticoagulant use and after discontinuation for bleeding 2.6 (2.4\u20132.8) versus 2.1 (1.5\u20132.8), venous thromboembolism 0.2 (0.1\u20130.2) versus 0.4 (0.2\u20130.7), and arterial thromboembolism 3.1 (2.9\u20133.3) versus 3.3 (2.6\u20134.2).<\/jats:p>\n                  <jats:p>Most VKA users with a life-limiting disease continued anticoagulant treatment during their last phase of life, with similar rates of bleeding and thromboembolic events during use and after discontinuation.<\/jats:p>","DOI":"10.1055\/a-2524-5334","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T19:07:31Z","timestamp":1737745651000},"page":"714-728","source":"Crossref","is-referenced-by-count":6,"title":["Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-Limiting Disease"],"prefix":"10.1055","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-8674","authenticated-orcid":false,"given":"Eva K.","family":"Kempers","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2025-1734","authenticated-orcid":false,"given":"Chantal","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C. T.","family":"Geijteman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilla","family":"Goedegebuur","sequence":"additional","affiliation":[{"name":"Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanneke E. A.","family":"Portielje","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"S\u00f8gaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Danish Center for Health Services Research, Aalborg University, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Center for General Practice, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Gulbech","family":"Ording","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Danish Center for Health Services Research, Aalborg University, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carline","family":"van den Dries","sequence":"additional","affiliation":[{"name":"Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Abbel","sequence":"additional","affiliation":[{"name":"Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"LUMC Center for Medicine for Older People, LUMC, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"Geersing","sequence":"additional","affiliation":[{"name":"Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Aldridge","sequence":"additional","affiliation":[{"name":"Population Data Science, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Lifford","sequence":"additional","affiliation":[{"name":"Division of Population Medicine, Wales Centre for Primary and Emergency Care Research (PRIME Centre Wales), Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Akbari","sequence":"additional","affiliation":[{"name":"Population Data Science, Faculty of Medicine, Health and Life Science, Swansea University, Swansea, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjef J. C. M.","family":"van de Leur","sequence":"additional","affiliation":[{"name":"Thrombosis Service, Isala Hospital Zwolle, Zwolle, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8647-7509","authenticated-orcid":false,"given":"Melchior C.","family":"Nierman","sequence":"additional","affiliation":[{"name":"Department of Thrombosis and Anticoagulation, Atalmedial Medical Diagnostic Centers, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-7880","authenticated-orcid":false,"given":"Isabelle","family":"Mah\u00e9","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Paris Cit\u00e9 University, Assistance Publique des H\u00f4pitaux de Paris, Louis Mourier Hospital, INSERM UMR_S1140, Innovations Th\u00e9rapeutiques en H\u00e9mostase, F-CRIN INNOVTE Network, Colombes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Mooijaart","sequence":"additional","affiliation":[{"name":"Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"LUMC Center for Medicine for Older People, LUMC, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Szmit","sequence":"additional","affiliation":[{"name":"Department of Cardio-Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Edwards","sequence":"additional","affiliation":[{"name":"Division of Population Medicine, Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon I. R.","family":"Noble","sequence":"additional","affiliation":[{"name":"Division of Population Medicine, Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, Wales, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[{"name":"Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[{"name":"Department of Medicine - Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-4871","authenticated-orcid":false,"given":"Marieke J. H. A.","family":"Kruip","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SERENITY consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"G Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"19","key":"ref2","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"T L Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jacc.2023.10.038","article-title":"When direct oral anticoagulants should not be standard treatment: JACC state-of-the-art review","volume":"83","author":"A Bejjani","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"05","key":"ref4","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"C M Otto","year":"2021","journal-title":"Circulation"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"J W Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"07","key":"ref6","first-page":"a2300067","article-title":"Apixaban or warfarin in patients with an On-X mechanical aortic valve","volume":"2","author":"T Y Wang","year":"2023","journal-title":"NEJM Evid"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0041-1725115","article-title":"Physicians' opinions on anticoagulant therapy in patients with a limited life expectancy","volume":"47","author":"B AA Huisman","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15360288.2018.1513435","article-title":"Adverse drug reactions in palliative care","volume":"32","author":"J O'Leary","year":"2018","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"I A Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"K Anderson","year":"2014","journal-title":"BMJ Open"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12904-021-00809-z","article-title":"Anticoagulation for patients with mechanical heart valves at the end of life: understanding clinician attitudes and improving decision making","volume":"20","author":"J Raby","year":"2021","journal-title":"BMC Palliat Care"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12904-021-00786-3","article-title":"Use of antithrombotics at the end of life: an in-depth chart review study","volume":"20","author":"B AA Huisman","year":"2021","journal-title":"BMC Palliat Care"},{"issue":"35","key":"ref15","doi-asserted-by":"crossref","first-page":"E1198","DOI":"10.1503\/cmaj.220919","article-title":"Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study","volume":"194","author":"N Chin-Yee","year":"2022","journal-title":"CMAJ"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jth.13606","article-title":"Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study","volume":"15","author":"B Tardy","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/S2352-3026(18)30215-1","article-title":"Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study","volume":"6","author":"C White","year":"2019","journal-title":"Lancet Haematol"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjmed.2021.01.031","article-title":"Increasing incidence and declining mortality after cancer-associated venous thromboembolism: a nationwide cohort study","volume":"134","author":"A G Ording","year":"2021","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"131271","DOI":"10.1016\/j.ijcard.2023.131271","article-title":"Risk of recurrent cancer-associated venous thromboembolism: a Danish nationwide cohort study","volume":"390","author":"A G Ording","year":"2023","journal-title":"Int J Cardiol"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-144-6-200603210-00005","article-title":"Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors","volume":"144","author":"I Tillie-Leblond","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-5273(02)00317-0","article-title":"Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?","volume":"87","author":"E V\u00e1zquez","year":"2003","journal-title":"Int J Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2018.12.028","article-title":"Thromboembolic disease in palliative and end-of-life care: a narrative review","volume":"175","author":"N Chin-Yee","year":"2019","journal-title":"Thromb Res"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgo.2021.07.009","article-title":"Use of potentially inappropriate medication in older patients with lung cancer at the end of life","volume":"13","author":"L Ham","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"08","key":"ref24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamainternmed.2021.1819","article-title":"Anticoagulant use for atrial fibrillation among persons with advanced dementia at the end of life","volume":"181","author":"G M Ouellet","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2023.05.008","article-title":"Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool","volume":"228","author":"J Goedegebuur","year":"2023","journal-title":"Thromb Res"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jth.15592","article-title":"Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: does low time in therapeutic range affect persistence?","volume":"20","author":"M MA Toorop","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref36","first-page":"272","volume-title":"TNM Classification of Malignant Tumours, 8th Edition","author":"J D Brierley","year":"2016"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jpainsymman.2019.03.006","article-title":"Identifying older adults with serious illness: transitioning from ICD-9 to ICD-10","volume":"57","author":"A S Kelley","year":"2019","journal-title":"J Pain Symptom Manage"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ehjcvp\/pvz014","article-title":"High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality","volume":"5","author":"O I Woudstra","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"M Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"446","key":"ref41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"J P Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"07","key":"ref43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.25494","article-title":"Bleeding incidence and risk factors among cancer patients treated with anticoagulation","volume":"94","author":"D E Angelini","year":"2019","journal-title":"Am J Hematol"},{"issue":"7498","key":"ref44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bmj.330.7498.1007","article-title":"Illness trajectories and palliative care","volume":"330","author":"S A Murray","year":"2005","journal-title":"BMJ"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e076625","DOI":"10.1136\/bmj-2023-076625","article-title":"Illness trajectories of incurable solid cancers","volume":"384","author":"E CT Geijteman","year":"2024","journal-title":"BMJ"},{"issue":"05","key":"ref46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline","volume":"34","author":"A Falanga","year":"2023","journal-title":"Ann Oncol"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/jgs.18512","article-title":"Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment","volume":"71","author":"Q Chen","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"13","key":"ref49","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.32044","article-title":"Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?","volume":"125","author":"L Morin","year":"2019","journal-title":"Cancer"},{"issue":"01","key":"ref50","first-page":"41","article-title":"Evaluation of the use of anticoagulotherapy in cancer patients in palliative care residence","volume":"4","author":"S Polesello","year":"2023","journal-title":"Palliat Med Rep"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2023.08.016","article-title":"Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: a daily practice evaluation","volume":"230","author":"G Chu","year":"2023","journal-title":"Thromb Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2021.04.024","article-title":"Therapeutic quality control in a regional thrombosis center: the effect of changing the target intensity of anticoagulation with vitamin K antagonists","volume":"203","author":"R P Van't Land","year":"2021","journal-title":"Thromb Res"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"e0164076","DOI":"10.1371\/journal.pone.0164076","article-title":"Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry","volume":"11","author":"S Haas","year":"2016","journal-title":"PLoS One"},{"issue":"08","key":"ref54","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jamainternmed.2016.3057","article-title":"Risk of bleeding and thrombosis in patients 70 years or older using vitamin K antagonists","volume":"176","author":"H A Kooistra","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/bmjspcare-2012-000220","article-title":"Defining the palliative care patient: its challenges and implications for service delivery","volume":"3","author":"H Mitchell","year":"2013","journal-title":"BMJ Support Palliat Care"},{"key":"ref57","first-page":"310","volume-title":"International Union against Cancer. In: TNM Classification of Malignant Tumours. 7th ed. 2009. ed","author":"L H Sobin","year":"2009"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2524-5334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:09:57Z","timestamp":1781910597000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2524-5334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":42,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2026,6,19]]},"published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2524-5334","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1,24]]},"published":{"date-parts":[[2025,1,24]]}}}